drugset / Trial / NCT07802730
Phase 1 PK Study of AERO-007, an Inhaled LABA+LAMA Combination for Nebulization Delivery in COPD Patients
Phase 1
Not yet recruiting
24 enrolled
AeroRx Therapeutics Inc.
Medicines Evaluation Unit Ltd · collab
RandomizedCrossoverOpen-labelTreatment
Summary
This is a phase 1, single-dose, 2-period crossover study in healthy volunteers to compare the systemic pharmacokinetic (PK) profile of inhaled AERO-002 versus inhaled active comparator product.
Timeline
- Start
- 2026-09
- Primary completion
- 2026-12
- Completion
- 2026-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Glycopyrrolate | Small molecule | 18 ug | Other |
| Comparator | Glycopyrrolate | Small molecule | 60 ug | Other |